Tag: psilocybin

Czech Republic Bill To Legalize Marijuana Home Cultivation And Allow Psilocybin For Medical Use Heads To President’s Desk

Lawmakers in the Czech Republic have passed a bill to reform the nation’s drug laws by legalizing simple possession and home cultivation of marijuana and allowing the use of psilocybin for medical purposes.

One month after the Chamber of Deputies approved the legislation, the Senate gave it final approval on Thursday. It now heads to the desk of President Petr Pavel to be signed into law.

The drug policy reforms are part of a package of amendments to the Czechia’s criminal code that supporters say will reduce spending on low-priority offenses, lower the number of people behind bars and reduce recidivism.

“The amendment will help criminal law better distinguish between truly socially harmful behavior and cases that do not belong in criminal proceedings at all,” outgoing Justice Minister Pavel Blažek said last month, according to a translated report from broadcaster Česká Televize (CT).

With respect to cannabis, the proposal would legalize possession of up to 100 grams of marijuana at home or 25 grams in public. Cultivation of up to three plants would also be allowed, though four or five plants would be a misdemeanor and more than that would be a felony. Possession of more than 200 grams would also carry criminal penalties.

Keep reading

Iowa Lawmaker Supporting Medical Psilocybin Bashes Bill That Would’ve Legalized Only A Synthetic Version Of The Psychedelic

An Iowa lawmaker who pushed for the passage of a bill to create a state program allowing the medicinal use of psilocybin said Gov. Kim Reynolds’s (R) decision to veto a bill pertaining to the psychoactive compound in magic mushrooms was a “great decision.”

Rep. Jeff Shipley (R-Fairfield) said rather than focus on rescheduling a synthetic version of the drug, the state should instead prioritize creating a state program legalizing the psychiatric use of naturally occurring psilocybin.

House File 383 would have allowed for the prescription and distribution of synthetic psilocybin immediately following federal approval of the drug, and mirrored a similar bill, which was signed into law, in Colorado.

The bill dealt with crystalline polymorph psilocybin, a compound commonly known as COMP360, which is a treatment developed by the biotechnology company Compass Pathways to help patients with treatment of resistant depression, post traumatic stress disorder and anorexia nervosa.

Shipley said he “condemns Compass Pathways” for its approach at creating, and patenting, a synthetic version of the “natural psilocybin that God has given us that everyone knows and loves.”

Compass Pathways declined to comment on the veto of the bill, which it lobbied in support of, and on Shipley’s comment.

Shipley’s emailed statement also apologized for his vote in favor of the bill, which passed unanimously in both the House and Senate.

“The proper legal framework is to reschedule psilocybin to schedule IV or III, and allow the relevant state regulatory boards to make it available as medicine,” Shipley said.

Reynolds, in her explanation of the veto, similarly said the state should have time to review any federal action on the synthetic version of the drug before it legalizes it at the state level.

Shipley was a vocal supporter of House File 978, which would have legalized the use of psilocybin for psychiatric treatment through a state program. The proposed program would have operated similarly to the state’s medical cannabis program.

The bill passed the House with an overwhelming majority in late April, but was not taken up by the Senate.

Keep reading

Just one single dose of ‘magic mushrooms’ could relieve depression for 5 years, researchers find

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study.

The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, followed up with patients who had been diagnosed with clinical depression — also known as major depressive disorder (MDD) — and had participated in a previous psilocybin treatment study in 2020.

“Most people who participated in our trial reported improvements in depression symptom intensity or in the ways in which they experienced depression in their life, lasting up to five years after the trial,” study co-author Alan Davis, director of the Center for Psychedelic Drug Research and Education at The Ohio State University, told Fox News Digital.

Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin in Toronto, Ontario, told Fox News Digital that the outcome speaks to the “exciting” potential of psilocybin and other psychedelic-based treatments in treating MDD and other mental health conditions.

“The results of the study are certainly very encouraging,” said Drysdale, who was not involved in the study.

Earlier studies pointed toward the possibility of psilocybin as a potential antidepressant, prompting researchers to conduct the first-ever randomized clinical trial.

Keep reading

Utah Passed a Religious Freedom Law. Then Cops Went After This Psychedelic Church.

When Bridger Lee Jensen opened a spiritual center in Provo, Utah, he contacted city officials to let them know the religious group he had founded, Singularism, would be conducting ceremonies involving a tea made from psilocybin mushrooms. “Singularism is optimistic that through partnership and dialogue, it can foster an environment that respects diversity and upholds individual rights,” Jensen wrote in a September 2023 letter to the Provo City Council and Mayor Michelle Kaufusi. Seeking to “establish an open line of communication” with local officials, Jensen invited them to ask questions and visit the center.

Jensen’s optimism proved to be unfounded. The city did not respond to his overture until more than a year later, when Provo police searched the Singularism center and seized the group’s sacrament: about 450 grams of psilocybin mushrooms from Oregon. The seizure resulted from an investigation in which an undercover officer posed as a would-be Singularism facilitator.

That raid happened in November 2024, less than eight months after Utah Gov. Spencer Cox, a Republican, had signed the state’s version of the federal Religious Freedom Restoration Act (RFRA). The state law likely protects Singularism’s psychedelic rituals, a federal judge ruled in February. U.S. District Judge Jill Parrish granted Jensen’s request for a preliminary injunction against city and county officials, ordering them to return the mushrooms and refrain from further interference with the group’s “sincere religious use of psilocybin” while the case is pending.

“In this litigation, the religious-exercise claims of a minority entheogenic religion put the State of Utah’s commitment to religious freedom to the test,” Parrish wrote in Jensen v. Utah County. If such a commitment “is to mean anything,” she said, it must protect “unpopular or unfamiliar religious groups” as well as “popular or familiar ones.”

Parrish noted that “the very founding of the State of Utah reflects the lived experience of that truth by members of the Church of Jesus Christ of Latter-day Saints.” In light of that history, she suggested, “it is ironic” that “not long after enacting its RFRA to provide special protections for religious exercise, the State of Utah should so vigorously deploy its resources, particularly the coercive power of its criminal-justice system, to harass and shut down a new religion it finds offensive practically without any evidence that [the] religion’s practices have imposed any harms on its own practitioners or anyone else.”

Under the federal RFRA, which Congress enacted in 1993, the government may not “substantially burden a person’s exercise of religion” unless it shows that the burden is “the least restrictive means” of furthering a “compelling governmental interest.” In 2006, the Supreme Court unanimously ruled that RFRA protected the American branch of a syncretic Brazil-based church from federal interference with its rituals, even though the group’s sacramental tea, ayahuasca, contained the otherwise illegal psychedelic drug dimethyltryptamine.

The Supreme Court has said RFRA cannot be applied to state and local governments. Laws like Utah’s, which 29 states have enacted, aim to fill that gap.

The defendants in Jensen’s case—Utah County Attorney Jeffrey Gray, the county, and the city of Provo—argued that Utah’s RFRA did not apply to Singularism, which they portrayed as a drug trafficking operation disguised as a religion. Parrish rejected that characterization. “Based on all the evidence in the record,” she wrote, “the court has no difficulty concluding that Plaintiffs are sincere in their beliefs and that those beliefs are religious in nature.”

Parrish also concluded that “preventing Singularism’s adherents from pursuing their spiritual voyages” imposed a substantial burden on their religious freedom that was not “the least restrictive means” of addressing the government’s public safety concerns. She noted that Utah allows religious use of peyote and has authorized “behavioral health treatment programs” in which patients can receive psilocybin.

Keep reading

Colorado Governor Grants Mass Psilocybin Pardon Following Voters’ Approval Of Psychedelics Legalization At The Ballot

The governor of Colorado has announced a first-ever round of mass pardons for people with psilocybin-related convictions.

Just about two weeks after Gov. Jared Polis (D) signed a bill into law empowering him and future governors to issue clemency for people who’ve committed psychedelics offenses, he announced during a speech at the Psychedelic Science 2025 conference on Wednesday that he’s exercising that authority.

The pardons he’s granting through executive order will provide relief to anyone with a state-level conviction for psilocybin and psilocyn possession.

Shortly after signing the legislation that now allows him to grant the pardons, Polis said the reform represents another step “towards a fairer future.” He’s advocated for the policy change since the state legalized certain entheogenic substances in 2022.

“Governor Polis is showing exactly the kind of courage and compassion that we hope to see from all governors across the country by using his executive authority to right the wrongs of prohibition and calling on Colorado municipalities to do the same,” Jason Ortiz, director of strategic initiatives for the Last Prisoner Project (LPP) told Marijuana Moment.

“I look forward to working with his office to support and empower local municipalities to carry the torch of freedom forward until there is no one burdened by a criminal history for actions that are now generating tax revenue across the state of Colorado,” he said.

The psychedelics clemency move comes several years after Polis issued mass pardons for people with prior marijuana convictions.

The recently enacted psychedelics legislation from Sen. Matt Ball (D) and Rep. Lisa Feret (D) authorizes governors to grant clemency to people with convictions for low-level possession of substances such as psilocybin, ibogaine and DMT that have since been legalized.

It will also require the Colorado Department of Public Health and Environment (CDPHE), Department of Revenue (DOR) and Department of Regulatory Agencies (DORA) to “collect information and data related to the use of natural medicine and natural medicine products.”

That must include data on law enforcement activities, adverse health events, consumer protection claims and behavioral impacts related to psychedelics.

Keep reading

Colorado Healing Center Facilitates First Psilocybin Session Under Voter-Approved Psychedelics Legalization Law

For the first time, a Colorado patient has taken a legal supervised dose of psilocybin under the state’s natural medicine program. That’s according to the The Center Origin, which in April became the state’s first licensed healing center as part of a buildout of the voter-approved system that was completed last month.

“Big news,” the facility’s CEO and founder, Elizabeth Cooke, said on social media on Sunday. “Last week, we held our very first psilocybin session for psychedelic-assisted healing.”

“A milestone moment is here and a new chapter in healing has begun!” she wrote. “This marks the beginning of our work offering safe, intentional, and transformative psychedelic-assisted healing experiences to those seeking deeper growth and restoration.”

Colorado regulators last month certified the first testing laboratory for the natural medicine program, putting the final piece of the state’s psychedelic infrastructure in place.

Following that step, Gov. Jared Polis (D) announced that the second-in-the-nation state psychedelics program was “fully launched for operations.”

Keep reading

Iowa Governor Vetoes Bill To Let Doctors Prescribe Psilocybin After Federal Approval Of The Psychedelic

Iowa Gov. Kim Reynolds (R) has vetoed a bill that would have allowed doctors in the state to immediately prescribe a form of psilocybin in the event of federal approval of the psychedelic substance by the U.S. Food and Drug Administration (FDA).

Reynolds, who announced her veto of a number of bills on Wednesday, said the lawmaker-approved legislation “surrenders state authority to make an informed determination about classification to federal officials at the FDA.”

The measure, HF 383, passed the Senate in April on a 47–0 vote after clearing the House 92–0 in February. If enacted, it would have reclassified the a form of psilocybin known as “crystalline polymorph psilocybin”—also known as COMP 360—in the event of FDA approval, allowing doctors and pharmacists to prescribe and dispense it in the state.

Similar measures were considered by other states this year, including Colorado—where Gov. Jared Polis (D) signed it into law—and Virginia, where it was vetoed by Gov. Glenn Youngkin (R).

“I recognize and respect the growing body of research into the potential therapeutic benefits of psilocybin for mental health conditions such as depression and PTSD,” Reynolds’s veto statement of the Iowa measure said. “However, this bill, in its current form, moves ahead of where our public health systems, regulatory frameworks, and law enforcement infrastructure are prepared to go at this time.”

“Psilocybin should first be FDA approved and rescheduled by the DEA before the State of Iowa considers rescheduling,” the governor added. “The pathway provided by this bill for legalization of psilocybin at the state level before we have a chance to review federal action and prepare robust, federally aligned guidelines and safeguards creates legal uncertainty, poses risks for misuse, and could undermine broader efforts to ensure safe and effective therapeutic use in the future.”

Reynolds framed the veto action as “not a dismissal of the emerging science or the sincere advocacy behind this legislation” but instead as “a call for a more deliberate and Iowa-centric approach—one that engages state and federal partners, provides time to review any clinical studies and federal changes, and builds a framework for any future therapeutic access that is clear, safe, equitable, and medically sound.”

Keep reading

A Rabbi, a Minister, a Monk, and a Priest Took Magic Mushrooms. Here’s What Happened

After scientists asked “psychedelic-naïve” professional religious leaders to take psilocybin, the active ingredient in magic mushrooms, most found the experience “religiously significant, meaningful, and generally beneficial.”

Historically, several world religions incorporate psychedelic compounds in their practices. However, this is the first study to examine what impact these experiences would have on the professional work of leaders from Christianity, Islam, Judaism, and Buddhism, four of the world’s major religions.

Magic Mushrooms and Mystical Experiences

In their published study, the late Roland Griffiths, of Johns Hopkins University, and Stephen Ross and Anthony Bossis, from New York University Grossman School of Medicine, discuss the role of psychedelic compounds like LSD, psilocybin, ayahuasca, and peyote in religious ceremonies. While uses of these substances vary among cultures and religions, the researchers note that they can induce experiences that share similarities to “non-pharmacologically triggered” experiences often described as “religious, spiritual, or mystical.”

“Mystical experiences are characterized by a range of subjective features including a sense of unity, “noetic” quality (e.g., an authoritative sense of truth), transcendence of time and space, a sense of awe or sacredness, intense positive mood, transiency that nevertheless feels timeless, presence in awareness of mutually exclusive states or concepts, and ineffability,” they explain.

The researchers note that such experiences are also sometimes observed in states of consciousness “associated with near-death experiences, meditation, prayer, fasting, breathwork, and music.” Although psychedelics continue to be used in some Indigenous religious contexts, the researchers note “they are generally not used within major world religions (e.g., Hinduism, Judaism, Buddhism, Christianity, Islam).”

Curious if these religious leaders would have similar experiences and how these experiences might affect their job performance, the team recruited volunteers from all four major religions. According to the results, the study participants experienced several impacts on their personal and professional lives, including “enduring increases in well-being and spirituality,” that lasted up to 16 months after taking magic mushrooms.

Keep reading

Federal Judge Allows Lawsuit Seeking Home Psilocybin Care To Proceed, Rejecting Oregon Officials’ Motion To Dismiss

More people in Oregon could eventually access legal psilocybin following a new federal court ruling in favor of plaintiffs who argued that the state’s first-in-the nation psilocybin law wrongfully prevents homebound patients from seeking care.

Four care providers—three licensed psilocybin facilitators and a physician specializing in advanced and terminal illnesses—sued the state about year ago, alleging that the state Psilocybin Services Act (PSA) discriminates against disabled individuals who can’t travel to designated service centers where the substance is administered.

The providers said they were told by the Oregon Health Authority (OHA) that there was no way to accommodate homebound patients under the state’s psilocybin law.

In an 12-page ruling issued late last month, District Judge Mustafa T. Kasubhai denied the state’s motion to dismiss the suit, opining that the plaintiffs have standing to bring the challenge and that a modification of the state’s psilocybin law to provide a reasonable accommodation to homebound patients under the federal Americans with Disabilities Act (ADA) would not violate principles of federalism.

“The Court agrees with Plaintiffs and finds that their requested remedy rests on physical access rather than use or distribution of a controlled substance in violation of state and federal laws,” the ruling says. “Plaintiffs do not ask the Court to order the provision of a controlled substance, as Defendants contend. Instead…Plaintiffs seek compliance with the ADA so that their disabled clients will have the same physical access to a service that is available to nondisabled individuals.”

Reached by email on Tuesday, plaintiffs’ attorney Kathryn Tucker, said she was pleased the court ruled in favor of the providers seeking to offer home psilocybin services.

“We are eager to ensure that homebound disabled and dying Oregonians can access psilocybin services, as they are among those most likely to benefit,” she wrote. “Opening access for these Oregonians will increase demand for psilocybin produced pursuant to the PSA as well as demand for services of facilitators, particularly those with expertise in providing care to disabled persons and those with advanced illness.”

“We hope to move this forward quickly now that the court has rejected the State’s effort to dismiss, recognizing that the ADA does apply to Oregon’s psilocybin program,” she added. “Because people with advancing illness may have little time left, delay in enabling access can mean that patients who might have obtained relief from debilitating anxiety and depression will die in unrelieved suffering.”

Notably, the new opinion, noted earlier by Psychedelic Week, does not order a specific remedy. It simply allows the underlying suit, Cusker v. Oregon Health Authority, to proceed toward a final decision.

Keep reading

Connecticut House Passes Psilocybin Decriminalization Bill To Remove Threat Of Jail For Possessing The Psychedelic

The Connecticut House of Representatives has approved a bill to decriminalize psilocybin for adults—despite lingering questions about whether the state’s Democratic governor would support it after he rejected an earlier version of the reform measure.

One month after the measure cleared the legislature’s Joint Judiciary Committee, it cleared the full chamber in a 74-65 vote on Monday. It now heads to the Senate for consideration.

If enacted into law, the legislation would make possession of up to one-half an ounce of psilocybin punishable by a $150 fine, without the threat of jail time.

“Psilocybin is a product which has been shown to be an effective therapeutic for various mental illnesses, including treating PTSD, addictions, depressions and anxiety disorders,” Rep. Steve Stafstrom (D), co-chair of the Judiciary Committee, said on the floor. “It is a substance that our state currently treats as the equivalent of cocaine, heroin or any other sort of serious Schedule I drug that, if folks are caught with possession of even a tiny little bit, Mr. Speaker, even even personal use of psilocybin, they’d be essentially subject to a class A misdemeanor and up to a year in jail.”

“What this bill seeks to do is pretty simple. It doesn’t legalize the substance. I want to be really clear: This bill does not legalize psilocybin,” he said. “If you’re dealing psilocybin, if you’re driving under the influence of psilocybin, those penalties remain the same as they are under existing law. Driving under the influence of psilocybin, it’s driving under the influence. No change in this bill. Dealing psilocybin continues to be drug dealer offense. You can be prosecuted for drug dealing—that does not change.”

Keep reading